Daniele Santini | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Emerging drugs for the treatment of bone metastasis	EXPERT OPINION ON EMERGING DRUGS	2015
Metabolic syndrome in castration-resistant prostate cancer patients treated with abiraterone	THE PROSTATE	2015
Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis	SUPPORTIVE CARE IN CANCER	2015
Basal and bevacizumab-based therapy-induced changes of lactate dehydrogenases and fibrinogen levels and clinical outcome of previously untreated metastatic colorectal cancer patients: a multicentric retrospective analysis	EXPERT OPINION ON BIOLOGICAL THERAPY	2015
Role of c-mesenchymal-epithelial transition pathway in gastric cancer	EXPERT OPINION ON PHARMACOTHERAPY	2015
hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma	BRITISH JOURNAL OF CANCER	2015
Role of gonadotropin-releasing hormone analogues in metastatic male breast cancer: results from a pooled analysis	JOURNAL OF HEMATOLOGY & ONCOLOGY	2015
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells	CANCER BIOLOGY & THERAPY	2015
Investigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer	EXPERT OPINION ON INVESTIGATIONAL DRUGS	2015
A key opinion leader interview with Prof D Santini: insight into cancer research	EXPERT OPINION ON THERAPEUTIC TARGETS	2015
Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen. A single institution experience	EXPERT REVIEW OF ANTICANCER THERAPY	2015
Natural History of Non-Small-Cell Lung Cancer with Bone Metastases	SCIENTIFIC REPORTS	2015
The route to personalized medicine in bladder cancer: where do we stand?	TARGETED ONCOLOGY	2015
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment	ONCOTARGET	2015
Designing a broad-spectrum integrative approach for cancer prevention and treatment	SEMINARS IN CANCER BIOLOGY	2015
Classic Kaposi Sarcoma: to treat or not to treat?	BMC RESEARCH NOTES	2015
The distinctive molecular, pathological and clinical characteristics of BRAF-mutant colorectal tumors	EXPERT REVIEW OF MOLECULAR DIAGNOSTICS	2015
Risk of pruritus in cancer patients treated with biological therapies: A systematic review and meta-analysis of clinical trials	CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY	2015
Metronomic chemotherapy from rationale to clinical studies: A dream or reality?	CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY	2015
Low Grade Serous Ovarian Carcinoma: From the molecular characterization to the best therapeutic strategy	JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH	2015